Page last updated: 2024-08-22

chloropyramine and Neuroblastoma

chloropyramine has been researched along with Neuroblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beierle, EA; Cance, WG; Kurenova, EV; Ma, X; Megison, M; Nabers, H; Stewart, JE	1

Other Studies

1 other study(ies) available for chloropyramine and Neuroblastoma

Article	Year
Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma. Molecular carcinogenesis, 2015, Volume: 54, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Movement; Cell Survival; Doxorubicin; Drug Synergism; Ethylenediamines; Female; Focal Adhesion Kinase 1; Humans; Mice; Mice, Nude; Neoplasms, Experimental; Neuroblastoma; Vascular Endothelial Growth Factor Receptor-3; Xenograft Model Antitumor Assays	2015

Article

Year

Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.

Molecular carcinogenesis, 2015, Volume: 54, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Movement; Cell Survival; Doxorubicin; Drug Synergism; Ethylenediamines; Female; Focal Adhesion Kinase 1; Humans; Mice; Mice, Nude; Neoplasms, Experimental; Neuroblastoma; Vascular Endothelial Growth Factor Receptor-3; Xenograft Model Antitumor Assays

2015